The 2026 outlook for mnts stock remains highly speculative as Momentus Inc. balances significant technical milestones with precarious financial health. Trading on the NASDAQ, the company recently reported a surge in operational momentum following a Space Act Agreement with NASA for in-orbit servicing and the successful delivery of its Vigoride-7 vehicle for a March 2026 launch with SpaceX. Despite these advancements, the share price has faced intense pressure, dropping approximately 20% since the start of 2026 to trade near $4.39. With a market capitalization of just $6.1 million and persistent "going concern" warnings due to a quarterly cash burn of $10 million to $15 million, investors are currently navigating a high-risk environment defined by potential equity dilution and the urgent need for sustainable revenue.
- Current Price: The mnts stock recently closed at $4.39 on the NASDAQ.
- Launch Catalyst: Vigoride-7 is scheduled for a pivotal launch aboard SpaceX’s Transporter-16 mission in March 2026.
- NASA Partnership: A new agreement aims to demonstrate rendezvous and proximity operations in low Earth orbit.
- Financial Risk: Short-term obligations exceed liquid assets, with a current ratio of only 0.41.
Current Price: The mnts stock recently closed at $4.39 on the NASDAQ.
Launch Catalyst: Vigoride-7 is scheduled for a pivotal launch aboard SpaceX’s Transporter-16 mission in March 2026.
NASA Partnership: A new agreement aims to demonstrate rendezvous and proximity operations in low Earth orbit.
Financial Risk: Short-term obligations exceed liquid assets, with a current ratio of only 0.41.
<div><img src="https://newzealand-finance.nz/wp-content/uploads/2026/03/mnts-stock-launch-performance.jpg"></div>
Understanding mnts stock performance in 2026
The trajectory of mnts stock in early 2026 has been a study in extreme volatility. While the stock soared over 80% in early February following news of government contract payments and technical progress, it has since retraced much of those gains. The company’s 52-week range reflects this turbulence, fluctuating between a high of $43.55 and a low of $3.82. For New Zealand-based investors tracking the space sector, Momentus represents a classic "penny stock" play where the valuation is tied more to binary technical outcomes—such as successful orbital deployments—than to traditional earnings metrics, which remain deeply negative.
| Period | Highest Price | Lowest Price | Net Movement |
| Year to Date (2026) | $15.96 | $3.84 | -20.08% |
| Last Financial Year | $11.70 | $0.37 | +166.98% |
| Current Month (Mar 2026) | $4.57 | $3.92 | Volatile |
| 52-Week Range | $43.55 | $3.81 | -88.09% |
Shareholder rebukes and dilution fatigue
A significant headwind for mnts stock in early 2026 was a rare shareholder rebuke during a special meeting in February. Stockholders blocked a management proposal to increase authorized shares from 250 million to 260 million, signaling widespread "dilution fatigue" after months of aggressive capital raising. To maintain operations, Momentus has relied heavily on warrant inducements and private placements, including a $5 million financing round in January 2026. While these moves provided a temporary lifeline, the constant issuance of new equity continues to cap the upside potential for existing shareholders.
Strategic partnerships and nasa collaborations
Despite its financial distress, the technical credibility of Momentus remains a core component of the mnts stock bull case. In February 2026, the company announced a landmark Space Act Agreement with NASA to advance in-orbit servicing capabilities. This mission involves using NASA's R5 Spacecraft as a free-flying imager for the Vigoride-7 vehicle to demonstrate formation flying and proximity maneuvers. Success in these demonstrations is critical, as it positions Momentus to capture a share of the emerging multi-billion dollar market for orbital infrastructure and satellite life extension.
Operational milestones and launch visibility
The most immediate catalyst for mnts stock is the Vigoride-7 mission, which is currently at Vandenberg Space Force Base awaiting its March launch with SpaceX. This mission carries multiple payloads for the U.S. Department of Defense and commercial customers, representing the first major revenue-generating opportunity for the firm in 2026. Additionally, Momentus has received approximately $1.9 million in payments for successful execution of previous Air Force and NASA contracts, proving that the company can meet strict government milestones despite its lean balance sheet. Read more in Wikipedia.
<div><img src="https://newzealand-finance.nz/wp-content/uploads/2026/03/mnts-vigoride-satellite-vehicle.jpg"></div>
Financial health and going concern warnings
For any holder of mnts stock, the company’s SEC filings provide a sobering view of its financial stability. Management has explicitly stated that the company's ability to continue as a going concern depends entirely on its ability to raise additional capital. With trailing twelve-month revenue of only $1.03 million and a deeply negative EBITDA of -$32.54 million, the current burn rate is unsustainable without constant external funding. Furthermore, the company’s operating margin of -26.69% significantly underperforms its aerospace peers, highlighting the immense difficulty of scaling space logistics technology.
| Health Metric | Current Value | Status |
| Cash on Hand | ~$1.6 Million (Dec 2025) | Critical |
| Current Ratio | 0.41 | Weak |
| EBITDA | -$32.54 Million (TTM) | Loss-making |
| Market Cap | $6.1 Million | Small Cap |
Analyst ratings and diverging sentiments
Market sentiment regarding mnts stock is sharply divided between institutional caution and retail optimism. A consensus of 7 analysts currently maintains a "Buy" rating, with an average price target of $4.10, suggesting the stock may already be trading near its fair value. However, retail interest on platforms like Stocktwits and Investing.com remains high, with some investors betting on a "moonshot" recovery if the March launch is successful. Conversely, bearish observers point to the $148.83 loss per share as evidence that the company may face bankruptcy before its technology reaches commercial maturity.
- Analyst Consensus: 85.71% "Buy" rating (based on small sample).
- Average Target: $4.10 per share.
- Bearish View: High probability of delisting if Nasdaq requirements aren't met.
- Bullish View: Projected 30% revenue growth for fiscal 2026 if contracts scale.
Analyst Consensus: 85.71% "Buy" rating (based on small sample).
Average Target: $4.10 per share.
Bearish View: High probability of delisting if Nasdaq requirements aren't met.
Bullish View: Projected 30% revenue growth for fiscal 2026 if contracts scale.
Technical analysis and exchange compliance
From a technical perspective, mnts stock is currently consolidating after its February rally. The stock hit a daily high of $4.39 in mid-March, which is roughly 90% down from its 52-week high of $43.55. To maintain its Nasdaq listing, Momentus completed a 1-for-17.85 reverse stock split in late 2025. While this move temporarily boosted the share price above the $1.00 requirement, the continued downward trend puts the company at risk of future compliance issues if the Vigoride-7 mission encounters any delays.
Innovation in space manufacturing
One bright spot for mnts stock is the company’s innovation in additive manufacturing. Momentus recently developed a 3D-printed fuel tank in collaboration with Velo3D, which is slated for flight testing on the upcoming Vigoride-7 mission. This technology is designed to reduce the weight and cost of orbital service vehicles, which could eventually improve the company’s gross margins if they can reach mass production. For long-term investors, these R&D milestones are the "seeds" of potential future value, though they require significant capital to sprout.
<div><img src="https://newzealand-finance.nz/wp-content/uploads/2026/03/mnts-space-manufacturing-tech.jpg"></div>
Risks and future catalysts to watch
Investing in mnts stock through the remainder of 2026 involves navigating several high-stakes risks. Beyond the obvious liquidity concerns, the company faces intense competition from established aerospace giants like Boeing and Lockheed Martin, as well as newer specialized rivals like Redwire and Sidus Space. Any technical failure during the SpaceX launch or a further delay in revenue realization from the NASA agreement could trigger a sharp decline in the stock’s value.
| Catalyst | Expected Timing | Potential Impact |
| Vigoride-7 Launch | March 2026 | High |
| NASA Mission Update | Q2 – Q3 2026 | Moderate |
| Quarterly Earnings | May 2026 | Critical (Cash Check) |
| Convertible Note Due | March 25, 2026 | High |
Final thoughts on mnts stock
In summary, mnts stock in 2026 is a "high-conviction" speculative asset that requires a high tolerance for risk. The combination of industry-leading technical partnerships with NASA and the imminent launch of Vigoride-7 provides a clear path for technical validation. However, the $1.6 million cash balance and the ongoing threat of shareholder dilution make it a dangerous hold for conservative portfolios. Success for Momentus this year will be defined by its ability to convert its $32 million contract backlog into actual cash flow while avoiding another major dilutive event.
mnts stock faq
Is mnts stock a buy sell or hold in 2026
The majority of analysts (85%) rate Momentus as a "Buy," though they warn of extreme risks related to the company's weak financial health.
What is the current share price of mnts stock
As of mid-March 2026, the stock is trading around $4.39 on the NASDAQ exchange.
Does mnts stock pay a dividend
No, Momentus Inc. does not pay a dividend as it is currently focused on survival and funding its research and development.
What is the 52 week high for mnts stock
The 52-week high for Momentus reached $43.55, which is significantly higher than its current trading range.
Why is mnts stock so volatile
Volatility is driven by the company's low market cap, its status as a "penny stock," and binary technical outcomes from its orbital missions.
What is vigoride 7 and why does it matter
Vigoride-7 is an orbital service vehicle designed to transport and deploy satellites. Its successful launch in March 2026 is critical for validating the company's business model.
Who is the ceo of momentus inc
The current CEO and Chairman of Momentus Inc. is John Charles Rood.
What is the market cap of mnts in 2026
As of March 2026, the market capitalization of Momentus is approximately $6.1 million.
How much cash does momentus have left
As of the last major report, the company had roughly $1.6 million in cash, which is low relative to its $10 million+ quarterly burn rate.
What are the main risks for mnts stock
The primary risks include total capital loss due to bankruptcy, massive dilution from new share issuances, and technical failure of its space missions.
